Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?

E-ISSN： 2212-5299|1|2|215-225

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.2, 2002-04, pp. : 215-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [ 3 H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

By Anderson J.J. Bradbury M.J. Giracello D.R. Chapman D.F. Holtz G. Roppe J. King C. Cosford N.D.P. Varney M.A.

European Journal of Pharmacology, Vol. 473, Iss. 1, 2003-07 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Inflammation alters the effects of mGlu receptor agonists on spinal nociceptive neurones

By Stanfa L.C. Dickenson A.H.

European Journal of Pharmacology, Vol. 347, Iss. 2, 1998-04 ,pp. : 165-172

Elsevier

Access to resources Recommend Favorite

Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block

By De Sarro G. Chimirri A. Meldrum B.S.

European Journal of Pharmacology, Vol. 451, Iss. 1, 2002-09 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders

By Oberman Lindsay M

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1819-1825

Informa Healthcare

Access to resources Recommend Favorite

Anticonvulsant activity of a mGlu 4 receptor selective agonist, (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid

By Chapman A.G. Talebi A. Yip P.K. Meldrum B.S.

European Journal of Pharmacology, Vol. 424, Iss. 2, 2001-07 ,pp. : 107-113

Elsevier

Access to resources Recommend Favorite